PROLARIS TEST/ PREDICTING RECURRENCE

This is a very interesting website discusses a technology
Prolaris)  offered by Myriad Genetics  suggesting that the risk of PCa recurrence(and even death) after primary therapy can be predicted with a degree of accuracy.  One could spend a great deal of time pursuing the various links, but for some, the time spent could prove quite helpful.  Can be a bit of a challenging read, but worthwhile.

 

I suggest that one click on the links "Information for Patients" and the other "Information for Physicians" for openers and then follow some of the links.

 

http://www.prolaristest.com/information-for-physicians/prolaris/

 

I have no opinion of validity.

 

 

BOOGEE,

I had one of these tests run at the University of Colorado Hospital. Mine came back as -0.4, or in the 37 percentile. Interpretation: For AUA low risk, 37% of the patients in the AUA low risk category had a lower Prolaris score. 10 year prostate cancer specific mortality rate at 1% with a 95% confidence interval. Interpretation: The patient has a 10 year mortality risk of 1% if managed conservatively. Mortality risks could be altered by various therapeutic interventions.

Good information to have I guess, at a pretty pricey cost.... $3400

BOOGEE,

Sorry for some reason my signature didn't show up?

Age 45, DX in March of 2013
3+3=6 4 of 12 cores positive
MRI neg.
Bone scan neg.
PSA 12/12 6.36
PSA 1/13 5.3 after being on antibiotics for 2 weeks